Phase I/II study of bortezomib‐melphalan‐prednisolone for previously untreated Japanese patients with multiple myeloma

This phase I/II study was conducted to evaluate the safety and efficacy of bortezomib‐melphalan‐prednisolone in Japanese patients with previously untreated multiple myeloma who are ineligible for hematopoietic stem cell transplantation. One hundred and one patients were enrolled, and 99 patients rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Ogawa, Yoshiaki, Suzuki, Kenshi, Sakai, Akira, Iida, Shinsuke, Ogura, Michinori, Tobinai, Kensei, Matsumoto, Morio, Matsue, Kosei, Terui, Yasuhito, Ohashi, Kazuteru, Ishii, Masami, Mukai, Harumi Y., Ando, Kiyoshi, Hotta, Tomomitsu
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2013
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657225/
https://ncbi.nlm.nih.gov/pubmed/23574271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12172
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados